
|Articles|January 26, 2015
- Head and Neck Cancers (Issue 3)
- Volume 3
- Issue 1
Body Composition and Targeted Therapies in Thyroid Cancer
Author(s)Lily Kwatampora, MD
Lily Kwatampora, MD, discusses the relationship between body composition and targeted therapies in patients with thyroid cancer.
Advertisement
Lily Kwatampora, MD, a 2nd year fellow from Baylor College of Medicine at The University of Texas MD Anderson Cancer Center, discusses the relationship between body composition and targeted therapies in patients with thyroid cancer.
<<<
Articles in this issue
almost 11 years ago
Perspectives From the Clinic on AE Management in Thyroid Canceralmost 11 years ago
Urging Families With Thyroid Cancer to Seek Genetic Testingalmost 11 years ago
Prognosis in Thyroid Cancer as Diverse as the Diseasealmost 11 years ago
The Diagnosis of Thyroid Canceralmost 11 years ago
National Surge in Thyroid Cancer Under Scrutinyalmost 11 years ago
The Challenges of Treating Follicular Cell-Derived Thyroid Carcinomaalmost 11 years ago
Epidemic in Sex-Related Oral Cancer Highlights Need for GuidelinesAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5










































